top
Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2
Ehjournal

Abstract Aims To describe the incidence of dyspnoea and its associations with demographic characteristics and clinical outcomes in patients with acute coronary syndromes (ACS) treated with ticagrelor ...

European Heart Journal, Storey, Robert F., Becker, Richard C., Harrington, Robert A., Husted, Steen, James, Stefan K., Cools, Frank, Steg, Philippe Gabriel, Khurmi, Nardev S., Emanuelsson, HÃ¥kan, ...

Date : 01/12/2011 Item size : 219428 bytes
Ehjournal

At that point, left ventricular hypertrophy (LVH) can lead to deleterious cardiovascular effects such as ventricular dysfunction, impaired coronary perfusion, and disturbances in cardiac rhythm.1 LVH ...

European Heart Journal, Westerhout, Cynthia M., Lauer, Michael S., James, Stefan, Fu, Yuling, Wallentin, Lars, Armstrong, Paul W.

Date : 01/09/2007 Item size : 274844 bytes
Ehjournal

Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke, major bleed, ...

European Heart Journal, Held, Claes, Hylek, Elaine M., Alexander, John H., Hanna, Michael, Lopes, Renato D., Wojdyla, Daniel M., Thomas, Laine, Al-Khalidi, Hussein, Alings, Marco, Xavier, Dennis, ...

Date : 21/05/2015
Ehjournal

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial Abstract Aims The ...

European Heart Journal, Husted, Steen, James, Stefan K., Bach, Richard G., Becker, Richard C., Budaj, Andrzej, Heras, Magda, Himmelmann, Anders, Horrow, Jay, Katus, Hugo A., Lassila, Riita, Morais, ...

Date : 14/06/2014 Item size : 305378 bytes
Ehjournal

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial Methods and results ...

European Heart Journal, Vinereanu, Dragos, Stevens, Susanna R., Alexander, John H., Al-Khatib, Sana M., Avezum, Alvaro, Bahit, Marıa Cecilia, Granger, Christopher B., Lopes, Renato D., Halvorsen, ...

Date : 07/12/2015 Item size : 304609 bytes
Ehjournal

To identify single-nucleotide polymorphisms (SNPs) associated with pharmacokinetics of ticagrelor and clinical outcomes, we performed a genome-wide association study (GWAS) in patients treated with ...

European Heart Journal, Varenhorst, Christoph, Eriksson, Niclas, Johansson, Åsa, Barratt, Bryan J., Hagström, Emil, Åkerblom, Axel, Syvänen, Ann-Christine, Becker, Richard C., James, ...

Date : 01/08/2015 Item size : 314510 bytes
Ehjournal

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Abstract Aims Bleeding in patients with coronary artery disease has been linked with ...

European Heart Journal, Budaj, Andrzej, Eikelboom, John W., Mehta, Shamir R., Afzal, Rizwan, Chrolavicius, Susan, Bassand, Jean-Pierre, Fox, Keith A.A., Wallentin, Lars, Peters, Ron J.G., Granger, ...

Date : 01/03/2009 Item size : 254245 bytes
Ehjournal

Abstract Aims To describe the incidence of dyspnoea and its associations with demographic characteristics and clinical outcomes in patients with acute coronary syndromes (ACS) treated with ticagrelor ...

European Heart Journal, Storey, Robert F., Becker, Richard C., Harrington, Robert A., Husted, Steen, James, Stefan K., Cools, Frank, Steg, Philippe Gabriel, Khurmi, Nardev S., Emanuelsson, HÃ¥kan, ...

Date : 01/12/2011
Ehjournal

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial Abstract Aims The ...

European Heart Journal, Husted, Steen, James, Stefan K., Bach, Richard G., Becker, Richard C., Budaj, Andrzej, Heras, Magda, Himmelmann, Anders, Horrow, Jay, Katus, Hugo A., Lassila, Riita, Morais, ...

Date : 14/06/2014 Item size : 315617 bytes
Ehjournal

At that point, left ventricular hypertrophy (LVH) can lead to deleterious cardiovascular effects such as ventricular dysfunction, impaired coronary perfusion, and disturbances in cardiac rhythm.1 LVH ...

European Heart Journal, Westerhout, Cynthia M., Lauer, Michael S., James, Stefan, Fu, Yuling, Wallentin, Lars, Armstrong, Paul W.

Date : 01/09/2007 Item size : 265649 bytes